Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Роль угрозы прерывания беременности в генезе развития фетоплацентарной недостаточности
Роль угрозы прерывания беременности в генезе развития фетоплацентарной недостаточности
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Doret M, Mellier G, Benchaib M et al. In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents. BJOG 2002; 109: 983.
2. Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020.
3. Thornton J. The quality of randomised trials of tocolysis. BJOG 2006; 113 (Suppl 3): 93.
4. Anotayanonth S, Subhedar NV, Garner P et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004: CD004352.
5. McPheeters ML, Miller WC, Hartmann KE et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005; 192: 1325.
6. Mittendorf R, Dambrosia J, Pryde PG et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111.
7. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007; 114: 289.
8. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002; CD001060.
9. Doyle LW, Crowther CA, Middleton P, Marret S. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2007; CD004661.
2. Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020.
3. Thornton J. The quality of randomised trials of tocolysis. BJOG 2006; 113 (Suppl 3): 93.
4. Anotayanonth S, Subhedar NV, Garner P et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004: CD004352.
5. McPheeters ML, Miller WC, Hartmann KE et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005; 192: 1325.
6. Mittendorf R, Dambrosia J, Pryde PG et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111.
7. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007; 114: 289.
8. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002; CD001060.
9. Doyle LW, Crowther CA, Middleton P, Marret S. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2007; CD004661.
2. Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020.
3. Thornton J. The quality of randomised trials of tocolysis. BJOG 2006; 113 (Suppl 3): 93.
4. Anotayanonth S, Subhedar NV, Garner P et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004: CD004352.
5. McPheeters ML, Miller WC, Hartmann KE et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005; 192: 1325.
6. Mittendorf R, Dambrosia J, Pryde PG et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111.
7. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007; 114: 289.
8. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002; CD001060.
9. Doyle LW, Crowther CA, Middleton P, Marret S. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2007; CD004661.
________________________________________________
2. Goldenberg RL. The management of preterm labor. Obstet Gynecol 2002; 100: 1020.
3. Thornton J. The quality of randomised trials of tocolysis. BJOG 2006; 113 (Suppl 3): 93.
4. Anotayanonth S, Subhedar NV, Garner P et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004: CD004352.
5. McPheeters ML, Miller WC, Hartmann KE et al. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005; 192: 1325.
6. Mittendorf R, Dambrosia J, Pryde PG et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 2002; 186: 1111.
7. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 2007; 114: 289.
8. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002; CD001060.
9. Doyle LW, Crowther CA, Middleton P, Marret S. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2007; CD004661.
Авторы
И.О.Макаров, Е.И.Боровкова, Н.А.Шешукова, И.В.Мартынова
Кафедра акушерства и гинекологии ФУВ Первого МГМУ им. И.М.Сеченова
(зав. кафедрой – проф. И.О.Макаров; ректор – член-кор. РАМН, проф. П.В.Глыбочко)
Кафедра акушерства и гинекологии ФУВ Первого МГМУ им. И.М.Сеченова
(зав. кафедрой – проф. И.О.Макаров; ректор – член-кор. РАМН, проф. П.В.Глыбочко)
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.